DOCSLIB.ORG

State of the Art for Healthcare Ontology D407.010

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
State of the Art for Healthcare Ontology D407.010 THE RESEARCH LEADING TO THESE RESULTS HAS RECEIVED FUNDING FROM THE EUROPEAN UNION’S SEVENTH FRAMEWORK PROGRAM (FP7/2007-2013) FOR CRYSTAL – CRITICAL SYSTEM ENGINEERING ACCELERATION JOINT UNDERTAKING UNDER GRANT AGREEMENT N° 332830 AND FROM SPECIFIC NATIONAL PROGRAMS AND / OR FUNDING AUTHORITIES. CRitical SYSTem Engineering AcceLeration State of the art for Healthcare ontology D407.010 State of the art for D407.010 Healthcare ontology DOCUMENT INFORMATION Project CRYSTAL Grant Agreement No. ARTEMIS-2012-1-332830 Deliverable Title State of the art for Healthcare ontology Deliverable No. D407.010 Dissemination Level PU Nature R Document Version V1.0 Date 2013-01-31 Contact M.A. van Bekkum Organization TNO Phone +31610968792 E-Mail [email protected] Version Nature Date Page V1.0 R 2014-01-31 2 of 54 State of the art for D407.010 Healthcare ontology AUTHORS TABLE Name Company E-Mail L. Oosterheert (lead editor) TNO [email protected] M.A. van Bekkum TNO [email protected] A.M. Farcasi TU/e [email protected] R. de Juan Marín ITI [email protected] E. Lluna ITI [email protected] R. Albers Philips [email protected] H.E.P. Cruts Philips [email protected] D. Segers Barco [email protected] T. van Velzen (external reviewer) IBM [email protected] T. Karbe (external reviewer) TU Berlin [email protected] CHANGE HISTORY Pages Version Date Reason for Change Affected 0.1 18-11-2013 Creation of Table of Contents (TNO) All Added preliminary content of chapters, first version of long 0.11 06-12-2013 7-13, Annex I list (TNO) 0.12 12-12-2013 Added action points for project partners (TNO) 7-13 0.2 23-12-2013 Chapters 3.1, 3.2 (TU/e), added standards to long list (ITI) 9-14, Annex I Elaboration on chapter 3.2 (TU/e, TNO), chapters 3.3, 4 0.3 13-01-2014 13-21, Annex I (TNO), added standards to long list (Barco, Philips) 0.9 20-01-2014 Chapters 5, 6, finalized document for review (TNO) All 1.0 31-01-2014 Chapters 1, 2, 4.1.1, 6, process review comments (TNO) All Version Nature Date Page V1.0 R 2014-01-31 3 of 54 State of the art for D407.010 Healthcare ontology CONTENT 1 INTRODUCTION ...................................................................................................................................................... 6 1.1 ROLE OF DELIVERABLE ....................................................................................................................................... 6 1.2 RELATIONSHIP TO OTHER CRYSTAL DOCUMENTS .......................................................................................... 6 1.3 STRUCTURE OF THIS DOCUMENT ....................................................................................................................... 7 2 SCOPE DEFINITION ............................................................................................................................................... 8 2.1 EXTENDING IOS ................................................................................................................................................. 9 2.2 INPUT FROM SP4 USE CASES .......................................................................................................................... 10 3 INTRODUCTION TO SEMANTICS ..................................................................................................................... 12 3.1 CLASSIFICATION OF SEMANTIC MODELS ........................................................................................................... 12 3.1.1 List ............................................................................................................................................................ 13 3.1.2 Taxonomy ................................................................................................................................................ 14 3.1.3 Thesaurus ............................................................................................................................................... 15 3.1.4 Ontology .................................................................................................................................................. 16 3.2 BASICS OF ONTOLOGIES ................................................................................................................................... 17 3.3 APPLICATION OF ONTOLOGIES IN THE HEALTHCARE SYSTEMS ENGINEERING DOMAIN ................................... 19 3.3.1 Example application from use cases ................................................................................................... 20 4 OVERVIEW OF STANDARDS WITHIN HEALTHCARE DOMAIN ............................................................... 22 4.1 LONG-LIST ......................................................................................................................................................... 22 4.1.1 Statistics of long-list ............................................................................................................................... 23 4.2 SHORT-LIST....................................................................................................................................................... 24 5 ANALYSIS OF SHORT-LIST............................................................................................................................... 26 5.1 SCOPE............................................................................................................................................................... 26 5.2 QUALITY MEASURES AND SEMANTIC LEVEL ...................................................................................................... 27 6 EVALUATION ........................................................................................................................................................ 28 7 TERMS, ABBREVIATIONS AND DEFINITIONS ............................................................................................. 29 8 REFERENCES ....................................................................................................................................................... 30 9 ANNEX .................................................................................................................................................................... 31 ANNEX I: LONG-LIST OF STANDARDS WITHIN THE HEALTHCARE DOMAIN .................................................................... 32 ANNEX II: DETAILS ON QUALITY MEASURES OF SHORT-LIST ........................................................................................ 54 Version Nature Date Page V1.0 R 2014-01-31 4 of 54 State of the art for D407.010 Healthcare ontology Content of Tables Figure 1-1: Research method ............................................................................................................................. 7 Figure 2-1: Scope of work package 4.7 .............................................................................................................. 8 Figure 2-2: Relation between semantics of domains and IOS ......................................................................... 10 Figure 2-3: Use cases versus domain ontology ............................................................................................... 10 Figure 3-1: Power and complexity of controlled vocabularies .......................................................................... 13 Figure 3-2: General structure of a semantic model - List ................................................................................. 13 Figure 3-3: General structure of a semantic model - Taxonomy ...................................................................... 14 Figure 3-4: General structure of a semantic model - Thesaurus ...................................................................... 15 Figure 3-5: General structure of a semantic model - Ontology ........................................................................ 16 Figure 3-6: Example of a vehicle ontology [Madsen B.N., 2009] ..................................................................... 17 Figure 3-7: V-Model for system engineering .................................................................................................... 19 Figure 3-8: Impact analysis of design changes [Cruts, H.E.P., 2013] .............................................................. 21 Figure 4-1: Topics of standards on long-list ..................................................................................................... 22 Figure 5-1: Standards of short-list plotted at semantic level and year of last update* ..................................... 27 Content of Figures Table 3-1: Application of ontologies within the engineering cycle .................................................................... 20 Table 4-1: Semantic levels of standards on the long-list .................................................................................. 23 Table 4-2: Top five of topics on the long-list ..................................................................................................... 23 Table 4-3: Short-list .......................................................................................................................................... 24 Table 4-4: Comparison between MDD, standards on short-list and FDA ........................................................ 25 Table 5-1: Classification of standards on short-list (inspired by [Gerber, C., 2008]) ........................................ 26 Table 7-1: Terms, Abbreviations
Load more

Recommended publications
  • Unlocking the Mystery of Third Party Reimbursement in Kinesiotherapy
    Unlocking the Mystery of Third Party Reimbursement In Kinesiotherapy Provided by the American Kinesiotherapy Association Written by Joanne Byron, LPN, BSNH, CHA, CMC, CPC, MCMC, PCS Edited & Contributions made by Carl Byron, III, ATC-L, EMT-I, CHA, CPC, MCMC Health Care Consulting Services, Inc. PO Box 572 Medina, Ohio 44258-0572 www.hccsincorp.com Page 2 Table of Contents Page Introduction – Bridging the Gap between KT and Payor 3 Key Elements to Reimbursement 4 Provider Enrollment 5 State of Health Insurance 9 Medicare Benefit Policy Manual 10 Reimbursement Basics 12 Documentation 13 Appropriate Coding 14 Procedure Coding – a 2 Tier System 15 CPT Assistant 16 Diagnosis Code Assignment ICD-9-CM 21 ICD-10-CM 22 Understanding the Health Insurance Industry 26 Types of insurance and reimbursement methodology 26 Managed Care Contracting Considerations 30 Administrative Simplification 33 NCQA 37 Managed Care Terminology (terms & definitions from HHS) 38 Provided by the American Kinesiotherapy Association (AKTA) & Written by Health Care Consulting Services, Inc. (HCCS) Copyright © 2010 AKTA & HCCS, All Rights Reserved This document is not intended to provide legal or consulting advice. It is for educational purposes only. Please retain an attorney or consultant for specific information for your practice. Page 3 Introduction Bridging the gap between KT and payer “How do we get paid?” . A challenging question every health care provider faces, regardless of specialty and health insurance company. The purpose of this reimbursement manual is to provide a basic understanding of health care reimbursement and compliance prior to filing claims for Kinesiotherapy services. Physical medicine budgets are getting ever tighter, demands on rehab specialists’ time and skills are increasing.
    [Show full text]
  • Ata Lements for Mergency Epartment Ystems
    D ata E lements for E mergency D epartment S ystems Release 1.0 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES CDCCENTERS FOR DISEASE CONTROL AND PREVENTION D ata E lements for E mergency D epartment S ystems Release 1.0 National Center for Injury Prevention and Control Atlanta, Georgia 1997 Data Elements for Emergency Department Systems, Release 1.0 (DEEDS) is the result of contributions by participants in the National Workshop on Emergency Department Data, held January 23-25, 1996, in Atlanta, Georgia, subsequent review and comment by individuals who read Release 1.0 in draft form, and finalization by a multidisciplinary writing committee. DEEDS is a set of recommendations published by the National Center for Injury Prevention and Control of the Centers for Disease Control and Prevention: Centers for Disease Control and Prevention David Satcher, MD, PhD, Director National Center for Injury Prevention and Control Mark L. Rosenberg, MD, MPP, Director Division of Acute Care, Rehabilitation Research, and Disability Prevention Richard J. Waxweiler, PhD, Director Acute Care Team Daniel A. Pollock, MD, Leader Production services were provided by the staff of the Office of Communication Resources, National Center for Injury Prevention and Control, and the Management Analysis and Services Office: Editing Valerie R. Johnson Cover Design and Layout Barbara B. Lord Use of trade names is for identification only and does not constitute endorsement by the U.S. Department of Health and Human Services. This document and subsequent revisions can be found at the National Center for Injury Prevention and Control Web site: http://www.cdc.gov/ncipc/pub-res/deedspage.htm Suggested Citation: National Center for Injury Prevention and Control.
    [Show full text]
  • Understanding Remittance Advice
    Understanding the Remittance Advice: A Guide for Medicare Providers, Physicians, Suppliers, and Billers March 2006 DISCLAIMER This Guide was current at the time it was printed or downloaded. Medicare policy changes frequently so links to the source documents have been provided within the Guide for your reference. This Guide was prepared as a tool to assist providers and is not intended to grant rights or impose obligations. Although every reasonable effort has been made to assure the accuracy of the information within these pages, the ultimate responsibility for the correct submission of claims and response to any remittance advice lies with the provider of services. The Centers for Medicare & Medicaid Services (CMS) employees, agents, and staff make no representation, warranty, or guarantee that this compilation of Medicare information is error- free and will bear no responsibility or liability for the results or consequences of the use of this Guide. This publication is a general summary that explains certain aspects of the Medicare Program, but is not a legal document. The official Medicare Program provisions are contained in the relevant laws, regulations, and rulings. For ease of reading this Guide, the term “provider” is used generally to refer to providers of all Medicare Part A and Part B services, supplies, and equipment. When information specific to a particular provider type is presented, the name of the specific provider type is used [e.g., physician, supplier, hospital, Skilled Nursing Facility (SNF)]. Institutional providers refer to hospitals, SNFs, Home Health Agencies (HHAs), hospices, and other facility-based health care organizations that submit claims to Fiscal Intermediaries (FIs) and Regional Home Health Intermediaries (RHHIs).
    [Show full text]
  • Month 2009 Issue
    NOTE: Should you have landed here as a result of a search engine (or other) link, be advised that these files contain material that is copyrighted by the American Medical Association. You are forbidden to download the files unless you read, agree to, and abide by the provisions of the copyright statement. Read the copyright statement now and you will be linked back to here. April 2010 Issue In This Advisory Part A Articles Part A LCD Updates Part B Articles Part B LCD Updates Part A & B Articles Forms & Documents Acronyms Monthly Feature Questions and Answers on Reporting Physician Consultation Services This article is for physicians and non-physician practitioners (NPPs) who perform initial evaluation and management (E/M) services previously reported by Current Procedural Terminology (CPT) consultation codes for Medicare beneficiaries and submit claims to Medicare Carriers and/or Medicare Administrative Contractors (MACs) for those services. It is also intended for Method II critical access hospitals, which bill for the services of those physicians and NPPs. Continued on Page 36 www.palmettogba.com/J1a www.palmettogba.com/J1b www.cms.hhs.gov Table of Contents J1 Part A ......................................................................................................................................1 Accumulation of Claims with Condition Code 04 on the Provider Statistical and Reimbursement Report (PS and R)............... 1 April 2010 Update of the Hospital Outpatient Prospective Payment System (OPPS)...............................................................
    [Show full text]
  • Billing and Payment
    Kaiser Permanente Northwest Provider Manual 2018 Billing and Payment We created this section of the manual to help guide you and your staff in working with Kaiser Permanente’s billing and payment policies and procedures. It provides a quick and easy resource with contact phone numbers, detailed processes, and site lists for services. If you have questions or concerns about this manual, contact our Provider Inquiry Department at 503-735-2727 or 1-866-441-1221. 2 Table of Contents Introduction ................................................................................................................. 4 Section 5: Billing and Payment ................................................................................... 4 5.1 Whom to Contact with Claims Questions ................................................... 5 5.2 Billing, Coding and Payment Instructions ................................................... 5 5.2.1 Electronic Claims (EDI) .............................................................................. 5 5.2.2 Paper Claim Forms .................................................................................... 6 5.3 Record Authorization Number .................................................................... 6 5.4 One Member/Provider per Claim Form ...................................................... 6 5.5 No Fault/Workers’ Compensation/Other Accident ..................................... 6 5.6 Entering Dates ........................................................................................... 7 5.7 Multiple
    [Show full text]
  • 20151122 NIS Protocol Template Including PASS
    1RQ,QWHUYHQWLRQDO6WXG\3URWRFRO 6WXG\3URWRFRO1XPEHU 06B 7LWOH $QRQLQWHUYHQWLRQDOUHJLVWHUEDVHGFRPSDUDWLYHHIIHFWLYHQHVVVWXG\RI UK)6+DOIDUHIHUHQFHSURGXFWYVKLJKO\SXULILHGKXPDQPHQRSDXVDO JRQDGRWURSLQRUUK)6+DOIDELRVLPLODUSURGXFWVIRURYDULDQVWLPXODWLRQ LQLQYLWURIHUWLOL]DWLRQRULQWUDF\WRSODVPLFVSHUPLQMHFWLRQWUHDWPHQWLQ 'HQPDUNDQG6ZHGHQ±7KH1RUGLF)ROOLWURSLQ$OID&RPSDUDWLYH (IIHFWLYHQHVV 125')$&( 6WXG\ 3URWRFROYHUVLRQLGHQWLILHU 3URWRFRO'DWH9HUVLRQ 0D\9HUVLRQ 5HSODFHV9HUVLRQ 0D\9HUVLRQ (83$6UHJLVWHUQXPEHU 6WXG\QRW\HWUHJLVWHUHG WREHUHJLVWHUHGLQ(83$6UHJLVWHU $FWLYHVXEVWDQFH **$)ROOLWURSLQDOID **$+XPDQPHQRSDXVDOJRQDGRWURSLQ 0HGLFLQDOSURGXFW )ROOLWURSLQ DOID UHFRPELQDQW KXPDQ IROOLFOHVWLPXODWLQJ KRUPRQH UK)6+ +XPDQPHQRSDXVDOJRQDGRWURSLQ 6SRQVRU 0HUFN+HDOWKFDUH.*D$ DQDIILOLDWHRI0HUFN.*D$'DUPVWDGW*HUPDQ\ )UDQNIXUWHU6WU 'DUPVWDGW*HUPDQ\ 5HVHDUFKTXHVWLRQDQG 7KH UHVHDUFK TXHVWLRQ LV ZKHWKHU DPRQJ ZRPHQ XQGHUJRLQJ LQ YLWUR REMHFWLYHV IHUWLOL]DWLRQ ,9) RULQWUDF\WRSODVPLFVSHUPLQMHFWLRQ ,&6, WUHDWPHQW UHFRPELQDQWKXPDQIROOLFOHVWLPXODWLQJKRUPRQH UK)6+ DOIDUHIHUHQFH SURGXFW LV DVVRFLDWHG ZLWK EHWWHU WUHDWPHQW UHVXOWV WKDQ KLJKO\ SXULILHG KXPDQ PHQRSDXVDO JRQDGRWURSLQ +3K0* RU UK)6+DOID ELRVLPLODU SURGXFWVLQWHUPVRIFOLQLFDOHIIHFWLYHQHVVDQGVDIHW\RXWFRPHV 3ULPDU\2EMHFWLYH 7KHSULPDU\REMHFWLYHRIWKLVVWXG\LVWRFRPSDUHUK)6+DOIDUHIHUHQFH SURGXFWZLWK+3K0*RUUK)6+DOIDELRVLPLODUSURGXFWVUHJDUGLQJWKH IROORZLQJOLYHELUWKRXWFRPHV D /LYHELUWKUDWHSHULQLWLDWHG,9),&6,VWLPXODWLRQF\FOH E &XPXODWLYHOLYHELUWKUDWHSHULQLWLDWHG,9),&6,VWLPXODWLRQ F\FOH F &XPXODWLYHOLYHELUWKUDWHLQXSWRILYHLQLWLDWHG,9),&6,
    [Show full text]
  • HISO 10030.2 Electronic Pharmaceutical Messaging Standard
    Electronic Pharmaceutical Messaging Standard HISO 10030.2 To be used in conjunction with HISO 10030.1 Electronic Pharmaceutical Business Processes Standard Copyright information This document has been approved as a standard for the New Zealand health and disability sector by the Health Information Standards Organisation (HISO), a sub-committee of HISAC. The copyright owner of this document is the Health Information Strategy Action Committee (HISAC), which is a ministerial committee appointed by the Minister of Health. HISO work on this document may be reproduced in any number of copies and in any format or medium provided: • the content is not changed; • the material is not sold; • the material is not used to promote or endorse any product or service; • the material is not used in an inappropriate or a misleading context having regard to the nature of the material; • any disclaimers included on the published information are reproduced on the material; • a copyright acknowledgment to the Health Information Strategy Action Committee is included. Permission to reproduce HISAC work does not extend to include any work identified in this document as the copyright material of a party other than HISAC. Authorisation to reproduce such material must be obtained from the copyright holders concerned. Published in November 2008 by HISAC PO Box 5013, Wellington, New Zealand ISBN 978-0-478-31780-0 (Online) This document is available on the HISAC website: http://www.hisac.govt.nz Electronic Pharmaceutical Messaging Standard v1 November 2008 2 Contents
    [Show full text]
  • Member of the Year
    May 2011 2010 Member of the Year Maryann Palmeter, CPC, CENTC Plus: 2011-2013 NAB • Modifier 33 • Template Caution • May MAYnia • Neurostimulation MLN CodingEdge Ad 5.2011 FINAL PRINT.pdf 1 3/9/11 12:29 PM R C M Y CM MY CY CMY K Contents 14 22 47 May 2011 [contents] In Every Issue 7 Letter from the President and CEO 8 Coding News 11 Letter from Member Leadership 12 Letters to the Editor 25 Kudos 42 Special Features Features Online Test Yourself – Earn 1 CEU 16 Modifier 33 Arrives Quietly But Packs a Punch go to www.aapc.com/resources/ Brad Ericson, MPC, CPC, COSC publications/coding-edge/archive.aspx 18 Use Templates with Caution 30 Welcome 2011-2013 NAB Peggy Stilley, CPC, CPMA, CPC-I, COBGC, ACS-OB 39 Audit Team Finds Paradise 22 Next Step in ED Leveling: Evaluation Methodologies Jim Strafford, CEDC, MCS-P 50 Minute with a Member 26 Educate Yourself on Proper E/M Caral Edelberg, CPC, CPMA, CAC, CCS-P, CHC Education 28 Maryann Palmeter: Coding, Compliance, and Cows 14 Ideas to Bring Your Chapter to Life Michelle A. Dick 38 Newly Credentialed Members 42 Append 22 to Unusually Difficult Procedures Sarah Reed, CPC, and G.J. Verhovshek, MA, CPC Coming Up 44 Learn What’s New for Neurostimulation G.J. Verhovshek, MA, CPC • Chapter of the Year • New AAPCCA 47 It’s Here: Rampant Health Care Fraud and Abuse Lynn Berry, PT, CPC • Interstitial Device Placement On the Cover: AAPC’s 2010 Member of the Year, Maryann C. Palmeter, CPC, CENTC, • Bundling Basics director of physician billing compliance at University of Florida Jacksonville Healthcare, Inc., found that the secret to happiness is the three Cs: coding, compliance, and cows.
    [Show full text]
  • Inleiding Meddra Versie 21.1
    Inleiding MedDRA versie 21.1 September 2018 000225 Kennisgeving aan de lezer Kennisgeving aan de lezer Deze Inleiding is in het Nederlands geschreven en dient uitsluitend voor gebruik met de Nederlandse versie van MedDRA. Er zijn aanvullende inleidingen ontwikkeld ter ondersteuning van andere talen dan het Engels. Deze dienen in vertaling te worden meegeleverd. De Inleiding dient voor gebruik in combinatie met de MedDRA Browsers, die verkrijgbaar zijn bij elk MedDRA-abonnement. Versiespecifieke wijzigingen of wijzigingen in de documentatie zijn te vinden in het document ‘Wat is nieuw'. Dit document is opgenomen met de MedDRA-versie, en is ook op de MSSO-website geplaatst in het gedeelte met ondersteunende documentatie. De MedDRA-terminologie wordt gehandhaafd onder een ISO 9001:2015 gedeponeerd kwaliteitsbeheersysteem. Er zijn geen wijzigingen van belang in de MedDRA-inleiding versie 21.1. Inleiding MedDRA versie 21.1 ii September 2018 000225 Dankbetuiging Dankbetuiging Het MedDRA®-handelsmerk is door IFPMA gedeponeerd namens de ICH. Ook worden de volgende informatiebronnen erkend: Diagnostical and Statistical Manual of Mental Disorders, vijfde editie (DSM-5) Copyright 2013 American Psychiatric Association. ICD-9-CM, International Classification of Diseases, negende druk, Clinical Modification, Copyright 1998 Medicode, Inc. COSTART Thesaurus vijfde druk, Copyright 1995 US Food and Drug Administration (FDA). Hoechst Adverse Reaction Terminology System (HARTS), Copyright 1992 Aventis Pharma. WHO Adverse Reaction Terminology (WHO-ART), Copyright 1998 World Health Organization Collaborating Centre for International Drug Monitoring. Japanese Adverse Reaction Terminology (J-ART) is een product van de Ministry of Health, Labour and Welfare (MHLW). LOINC is een gedeponeerd handelsmerk van Regenstrief Institute, Inc. Lanoxin is een gedeponeerd handelsmerk van GlaxoSmithKline.
    [Show full text]
  • HISO 10030.1 Electronic Pharmaceutical
    Electronic Pharmaceutical Business Process Standard HISO 10030.1 To be used in conjunction with HISO 10030.2 Electronic Pharmaceutical Messaging Standard Copyright Information This document has been approved as a Standard for the New Zealand health and disability sector by the Health Information Standards Organisation (HISO), a sub-committee of the Health Information Strategy Action Committee (HISAC), which is a ministerial committee appointed by the Minister of Health. HISAC is the copyright owner of this document. HISO work on this document may be reproduced in any number of copies and in any format or medium provided: • the content is not changed; • the material is not sold; • the material is not used to promote or endorse any product or service; • the material is not used in an inappropriate or a misleading context having regard to the nature of the material; • any disclaimers included on the published information are reproduced on the material; • a copyright acknowledgment to the Health Information Strategy Action Committee is included. Permission to reproduce HISAC work does not extend to include any work identified in this document as the copyright material of a party other than HISAC. Authorisation to reproduce such material must be obtained from the copyright holders concerned. Published in October 2008 by HISAC PO Box 5013, Wellington, New Zealand ISBN 978-0-478-31777-0 (Online) This document is available on the HISAC website: http://www.hisac.govt.nz EPharmaceutical Business Process v1 Page 2 of 57 October 2008 Contents 1 Introduction
    [Show full text]
  • Developing a Coding Compliance Program 5
    C HAPTER Developing a Coding Compliance Program 5 Objectives At the completion of this chapter, the learner should be able to: • Identify the seven key components of a corporate compliance program. • Describe the importance of a corporate compliance program and the purpose of a coding compliance program. • Discuss the purpose of the Offi ce of Inspector General’s compliance guidance for health care entities and identify key elements. • Describe the difference between “mandatory” and “permissive” offenses. • Discuss the roles of the coding compliance manager and the coding compliance committee. • Identify areas that should be defi ned within coding compliance policies. • Discuss the importance of coding compliance education. • Recognize the importance of coding accuracy and distinguish between coding and documentation errors. • Explain differences in coding certifi cation and professional coding organizations. • Identify the coding resources that must be kept up to date. Key Terms chargemaster coding resources mandatory exclusions Recovery Audit code of conduct compliance offi cer OIG Compliance Contractors (RACs) coding certifi cation compliance program Guidance structure coding compliance Comprehensive Error outcomes coding compliance Rate Testing (CERT) outcome indicators education program permissive exclusions Coding Compliance corporate compliance process Manager program 2009 Current Procedural Terminology © 2008 American Medical Association. All Rights Reserved. 3921X_05_ch05_p093-118.indd 93 9/29/09 2:40:45 PM 94 Chapter 5 Developing a Coding Compliance Program Integrating Coding and Corporate Compliance Corporate businesses and health care organizations alike may be subject to criminal and civil actions under a variety of federal and state laws, including the False Claims Act, the Wire and Mail Fraud Act, securities and employment laws, and a number of others.
    [Show full text]
  • How Different Databases Shape Epidemiological Research Questions 2020
    The elderly, the young, and the ill: How different databases shape epidemiological research questions Inauguraldissertation zur Erlangung der Würde eines Doktors der Philosophie vorgelegt der Philosophisch-Naturwissenschaftlichen Fakultät der Universität Basel von Rahel Schneider 2020 Originaldokument gespeichert auf dem Dokumentenserver der Universität Basel edoc.unibas.ch Genehmigt von der Philosophisch-Naturwissenschaftlichen Fakultät Auf Antrag von Prof. Dr. Christoph R. Meier Prof. Dr. Kurt E. Hersberger Prof. Dr. David Schwappach Basel, den 26. Mai 2020 Prof. Dr. Martin Spiess Dekan Inference - Sämy Steiger, Swiss artist and architect « Words are, in my not-so-humble opinion, our most inexhaustible source of magic. Capable of both inflicting injury, and remedying it. » Dumbledore - Harry Potter and the Deathly Hallows Acknowledgements The work presented in this thesis was conducted between December 2016 and May 2020 at the Basel Pharmacoepidemiology Unit at the Institute for Clinical Pharmacy and Epidemiology of the University of Basel. ‘It takes a village to raise a child’ is an African proverb that says it needs an entire community of people to interact with children for them to experience and grow in a safe and healthy environment. In my case, it has indeed taken a village. Not to raise me as a child, but to raise me as an epidemiologist. The support, assistance, and trust of the people mentioned in this chapter was of immeasurable value for the successful outcome of this project, and fills my heart with gratitude. First and foremost, my special thank goes to Prof. Dr. Christoph Meier, without whom this thesis would not have been possible. Thank you, Christoph, for your unlimited trust and kindness, and for sharing your brilliant expertise of pharmacoepidemiology with me.
    [Show full text]